Cairo – Mubasher: October Pharma recorded a surge of 402% in net profits to EGP 40.59 million during the first quarter (Q1) of 2021, compared to EGP 8.08 million in the same quarter a year ago.
Revenues increased by 38% to total EGP 165.83 million in Q1-21 from EGP 120.23 million in Q1-20, according to a bourse disclosure on Sunday.
The company’s earnings per share stood at EGP 6.77 in the first three months of 2021, compared to EGP 1.35 in the same period last year.
October Pharma earlier registered an annual growth of 161% in net profits to EGP 88.26 million in 2020.
